INDUCTION OF GRAFT-VERSUS-HOST DISEASE AFTER AUTOLOGOUS BONE MARROW TRANSPLANTATION
- 1 April 1989
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 333 (8641), 754-757
- https://doi.org/10.1016/s0140-6736(89)92575-0
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Effects of Cyclosporine A on T Cell Development and Clonal DeletionScience, 1988
- T CELL DEPLETION WITH CAMPATH-1 IN ALLOGENEIC BONE MARROW TRANSPLANTATIONTransplantation, 1988
- Thymus and autoimmunity. Transplantation of the thymus from cyclosporin A-treated mice causes organ-specific autoimmune disease in athymic nude mice.The Journal of Experimental Medicine, 1988
- Comparison of Autologous and Allogeneic Bone Marrow Transplantation for Treatment of High-Risk Refractory Acute Lymphoblastic LeukemiaNew England Journal of Medicine, 1987
- High-Dose Therapy and Autologous Bone Marrow Transplantation after Failure of Conventional Chemotherapy in Adults with Intermediate-Grade or High-Grade Non-Hodgkin's LymphomaNew England Journal of Medicine, 1987
- Acute graft-vs-host disease. Development following autologous and syngeneic bone marrow transplantationArchives of Dermatology, 1987
- Methotrexate and Cyclosporine Compared with Cyclosporine Alone for Prophylaxis of Acute Graft versus Host Disease after Marrow Transplantation for LeukemiaNew England Journal of Medicine, 1986
- Development of graft-vs.-host disease-like syndrome in cyclosporine-treated rats after syngeneic bone marrow transplantation. I. Development of cytotoxic T lymphocytes with apparent polyclonal anti-Ia specificity, including autoreactivity.The Journal of Experimental Medicine, 1985
- HOW DOES BONE-MARROW TRANSPLANTATION CURE LEUKAEMIA?The Lancet, 1984
- Myasthenia Gravis after Bone-Marrow TransplantationNew England Journal of Medicine, 1983